LCMS
Další informace
WebinářeO násKontaktujte násPodmínky užití
LabRulez s.r.o. Všechna práva vyhrazena. Obsah dostupný pod licencí CC BY-SA 4.0 Uveďte původ-Zachovejte licenci.
Pořadatel
Shimadzu Corporation
Shimadzu Corporation
Společnost Shimadzu vyrábí nejširší sortiment přístrojů pro instrumentální analytiku, testování materiálů a life science.
Tagy
LC/MS
LinkedIn Logo

Integrating powers of MS and Spectroscopy - Solutions for mAB characterization

ZÁZNAM | Proběhlo Pá, 1.7.2022
Analytická řešení vyvinutá ve společnosti Shimadzu, která mohou pomoci při vytváření pracovních postupů pro objevování mAb.
Přejít na webinář
Shimadzu: Integrating powers of MS and Spectroscopy - Solutions for mAB characterization
Shimadzu: Integrating powers of MS and Spectroscopy - Solutions for mAB characterization

Shimadzu Total Lab for Biopharma provides innovative and versatile analytical solutions for the biopharmaceutical market with a comprehensive range of instruments including LC/MS and Spectroscopy.

In this seminar we would like to introduce analytical solutions developed at Shimadzu that can help in establishing workflow for mAb discovery, clinical evaluation, biosimilar characterization, process development and QA/QC for batch release testing.

Learning Objectives:
  • Structure and funciton of monoclonal antibody

  • Shimadzu application for mAb characterization

  • The range of instruments Shimadzu can offer for these workflow

Presenter: Dr. Wang Tianhua (Product Specialist, Shimadzu Asia Pacific)

Tianhua did his PhD in University of Pennsylvania (Chemical and Biomolecular Engineering). He then spent 5 years in the analytics group at Bioprocessing Technology Institute. His research interest includes drug discovery for infectious disease (SARS-CoV and Ebola), biopharmaceutical production system optimization and mAb Characterization with particular focus in glycan profiling and glycomics study. Tianhua joined Shimadzu in 2017 as a product specialist for life science products.

Presenter: Nicole Zhang (Senior Product Specialist, Shimadzu Asia Pacific)

Nicole studies in UK in Microbiology and Immunology, prior joining Shimadzu, she worked in different companies in analytical instrument industry for more than 10 years, from Chemist to marketing and in charge of different technologies from LC, MS to Spectro products. She joined Shimadzu at the year of 2018 as spectroscopy product specialist and in charge of food quality and safety market.

Shimadzu Corporation
LinkedIn Logo
 

Mohlo by Vás zajímat

Simultaneous Quantitation and Discovery analysis: Combining targeted and untargeted metabolomics on Orbitrap mass spectrometers

Aplikace
| 2026 | Thermo Fisher Scientific
Instrumentace
LC/MS, LC/MS/MS, LC/Orbitrap, LC/HRMS
Výrobce
Thermo Fisher Scientific
Zaměření
Metabolomika

Analysis of Per- and Polyfluoroalkyl Substances (PFAS) in Wastewater

Aplikace
| 2026 | Agilent Technologies
Instrumentace
LC/MS, LC/MS/MS, LC/QQQ
Výrobce
Agilent Technologies
Zaměření
Životní prostředí

Non-Targeted Screening of Biosolids with the Xevo™ MRT Mass Spectrometer Reveals New Isoforms of PFAS

Aplikace
| 2026 | Waters
Instrumentace
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Výrobce
Waters
Zaměření
Životní prostředí

High Resolution Characterization of Lipid Nanoparticles Using the Xevo™ Charge Detection Mass Spectrometry (CDMS) Instrument - Single Particle Mass Analysis of Intact LNP-mRNA Formulations

Aplikace
| 2026 | Waters
Instrumentace
LC/MS, LC/MS/MS, LC/HRMS, Charakterizace částic, LC/IT
Výrobce
Waters
Zaměření
Lipidomika

Out-of-the-box workflow for PFAS quantitation using a fullscan high-resolution approach with the Orbitrap Exploris EFOX Mass Detector

Aplikace
| 2025 | Thermo Fisher Scientific
Instrumentace
LC/MS, LC/MS/MS, LC/Orbitrap, LC/HRMS
Výrobce
Thermo Fisher Scientific
Zaměření
Životní prostředí
Další projekty
GCMS
ICPMS
Sledujte nás
FacebookX (Twitter)LinkedInYouTube
Další informace
WebinářeO násKontaktujte násPodmínky užití
LabRulez s.r.o. Všechna práva vyhrazena. Obsah dostupný pod licencí CC BY-SA 4.0 Uveďte původ-Zachovejte licenci.